Otitis Media, Suppurative Clinical Trial
— OMA-IAOfficial title:
Assessment of an App Based on Artificial Intelligence for Purulent Acute Otitis Media (AOM) Diagnosis in a a Pediatric Emergency Department
Verified date | March 2023 |
Source | Fondation Lenval |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Otitis media (OM) is one of the most common childhood infections and is a major cause of morbidity in children and results as being the first cause of antibiotic prescription among children in developed countries . An artificial intelligence-based tool could help physicians refine their diagnosis
Status | Completed |
Enrollment | 203 |
Est. completion date | March 16, 2023 |
Est. primary completion date | August 16, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 17 Years |
Eligibility | Inclusion Criteria: Child under 18 years Presenting signs that may suggest acute otitis media (fever, earache, purulent otorrhea) For which the informed written consent of, at least, one of the two parents or the holder of parental authority has been obtained Exclusion Criteria: A sign (s) of vital distress Trans-tympanic drains - |
Country | Name | City | State |
---|---|---|---|
France | Hôpitaux Pédiatrique de Nice CHU Lenval | Nice |
Lead Sponsor | Collaborator |
---|---|
Fondation Lenval |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | diagnosis of purulent Acute Otitis Media (AOM) made by junior physicians using the i-Nside application associated with Smartscope® | diagnosis of purulent AOM is made on an inflammatory aspect of the eardrum with retrotympanic effusion, exteriorized (otorrhea) or not (opacity, effacement of reliefs or bulging, disappearance of the light triangle). | at inclusion | |
Primary | diagnosis of purulent Acute Otitis Media (AOM) made by senior physicians using a standard otoscope | diagnosis of purulent AOM is made on an inflammatory aspect of the eardrum with retrotympanic effusion, exteriorized (otorrhea) or not (opacity, effacement of reliefs or bulging, disappearance of the light triangle) | at inclusion | |
Secondary | rate of misdiagnoses of purulent Acute Otitis Media (AOM) with and without the use of the application | a misdiagnosis is measured by a discordant diagnosis of the juniors compared to the seniors considered as the Gold Standard for the AOM diagnosis | at inclusion | |
Secondary | collection risk factors for a discrepancy in the diagnosis of purulent AOM | collection data of age of patients,pain requiring analgesia, period of the day of diagnosis (morning, afternoon,night) | at inclusion | |
Secondary | satisfaction of junior physicians regarding the use of the app | a questionnaire will be given at the end of the study. The questions relate to the use of the application and its perceived usefulness by practitioners. Satisfaction will be assessed by a Lickert scale | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01244581 -
Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily Tympanometry
|
Phase 3 | |
Completed |
NCT05605262 -
Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing.
|
Phase 2/Phase 3 | |
Terminated |
NCT00315003 -
TELI COM - Telithromycin in Children With Otitis Media
|
Phase 3 |